396 related articles for article (PubMed ID: 19014931)
1. CS-917, a fructose 1,6-bisphosphatase inhibitor, improves postprandial hyperglycemia after meal loading in non-obese type 2 diabetic Goto-Kakizaki rats.
Yoshida T; Okuno A; Izumi M; Takahashi K; Hagisawa Y; Ohsumi J; Fujiwara T
Eur J Pharmacol; 2008 Dec; 601(1-3):192-7. PubMed ID: 19014931
[TBL] [Abstract][Full Text] [Related]
2. Metformin primarily decreases plasma glucose not by gluconeogenesis suppression but by activating glucose utilization in a non-obese type 2 diabetes Goto-Kakizaki rats.
Yoshida T; Okuno A; Tanaka J; Takahashi K; Nakashima R; Kanda S; Ogawa J; Hagisawa Y; Fujiwara T
Eur J Pharmacol; 2009 Nov; 623(1-3):141-7. PubMed ID: 19765581
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of fructose 1,6-bisphosphatase reduces excessive endogenous glucose production and attenuates hyperglycemia in Zucker diabetic fatty rats.
van Poelje PD; Potter SC; Chandramouli VC; Landau BR; Dang Q; Erion MD
Diabetes; 2006 Jun; 55(6):1747-54. PubMed ID: 16731838
[TBL] [Abstract][Full Text] [Related]
4. Fructose-1, 6-bisphosphatase inhibitors for reducing excessive endogenous glucose production in type 2 diabetes.
van Poelje PD; Potter SC; Erion MD
Handb Exp Pharmacol; 2011; (203):279-301. PubMed ID: 21484576
[TBL] [Abstract][Full Text] [Related]
5. Contributions of hepatic gluconeogenesis suppression and compensative glycogenolysis on the glucose-lowering effect of CS-917, a fructose 1,6-bisphosphatase inhibitor, in non-obese type 2 diabetes Goto-Kakizaki rats.
Yoshida T; Okuno A; Takahashi K; Ogawa J; Hagisawa Y; Kanda S; Fujiwara T
J Pharmacol Sci; 2011; 115(3):329-35. PubMed ID: 21350313
[TBL] [Abstract][Full Text] [Related]
6. MB06322 (CS-917): A potent and selective inhibitor of fructose 1,6-bisphosphatase for controlling gluconeogenesis in type 2 diabetes.
Erion MD; van Poelje PD; Dang Q; Kasibhatla SR; Potter SC; Reddy MR; Reddy KR; Jiang T; Lipscomb WN
Proc Natl Acad Sci U S A; 2005 May; 102(22):7970-5. PubMed ID: 15911772
[TBL] [Abstract][Full Text] [Related]
7. Long-term treatment with the Na+-glucose cotransporter inhibitor T-1095 causes sustained improvement in hyperglycemia and prevents diabetic neuropathy in Goto-Kakizaki Rats.
Ueta K; Ishihara T; Matsumoto Y; Oku A; Nawano M; Fujita T; Saito A; Arakawa K
Life Sci; 2005 Apr; 76(23):2655-68. PubMed ID: 15792833
[TBL] [Abstract][Full Text] [Related]
8. Acarbose, an alpha-glucosidase inhibitor, improves endothelial dysfunction in Goto-Kakizaki rats exhibiting repetitive blood glucose fluctuation.
Azuma K; Toyofuku Y; Iesaki T; Otsuka A; Tanaka A; Mita T; Hirose T; Tanaka Y; Daida H; Kawamori R; Watada H
Biochem Biophys Res Commun; 2006 Jun; 345(2):688-93. PubMed ID: 16696939
[TBL] [Abstract][Full Text] [Related]
9. Discovery of potent and specific fructose-1,6-bisphosphatase inhibitors and a series of orally-bioavailable phosphoramidase-sensitive prodrugs for the treatment of type 2 diabetes.
Dang Q; Kasibhatla SR; Reddy KR; Jiang T; Reddy MR; Potter SC; Fujitaki JM; van Poelje PD; Huang J; Lipscomb WN; Erion MD
J Am Chem Soc; 2007 Dec; 129(50):15491-502. PubMed ID: 18041834
[TBL] [Abstract][Full Text] [Related]
10. [Recent advance in the discovery of allosteric inhibitors binding to the AMP site of fructose-1,6-bisphosphatase].
Li ZM; Bie JB; Song HR; Xu BL
Yao Xue Xue Bao; 2011 Nov; 46(11):1291-300. PubMed ID: 22260018
[TBL] [Abstract][Full Text] [Related]
11. Effects of miglitol, an alpha-glucosidase inhibitor, on glycaemic status and histopathological changes in islets in non-obese, non-insulin-dependent diabetic Goto-Kakizaki rats.
Goda T; Suruga K; Komori A; Kuranuki S; Mochizuki K; Makita Y; Kumazawa T
Br J Nutr; 2007 Oct; 98(4):702-10. PubMed ID: 17537288
[TBL] [Abstract][Full Text] [Related]
12. Punica granatum flower extract, a potent alpha-glucosidase inhibitor, improves postprandial hyperglycemia in Zucker diabetic fatty rats.
Li Y; Wen S; Kota BP; Peng G; Li GQ; Yamahara J; Roufogalis BD
J Ethnopharmacol; 2005 Jun; 99(2):239-44. PubMed ID: 15894133
[TBL] [Abstract][Full Text] [Related]
13. Reversible hyperglycemia in rats following acute exposure to acephate, an organophosphorus insecticide: role of gluconeogenesis.
Joshi AK; Rajini PS
Toxicology; 2009 Mar; 257(1-2):40-5. PubMed ID: 19118596
[TBL] [Abstract][Full Text] [Related]
14. Effect of the organophosphorus pesticide diazinon on glucose tolerance in type 2 diabetic rats.
Ueyama J; Kamijima M; Asai K; Mochizuki A; Wang D; Kondo T; Suzuki T; Takagi K; Takagi K; Kanazawa H; Miyamoto K; Wakusawa S; Hasegawa T
Toxicol Lett; 2008 Nov; 182(1-3):42-7. PubMed ID: 18789379
[TBL] [Abstract][Full Text] [Related]
15. Increased secretion and expression of amylin in spontaneously diabetic Goto-Kakizaki rats treated with rhGLP-1 (7-36).
Weng HB; Gu Q; Liu M; Cheng NN; Li D; Gao X
Acta Pharmacol Sin; 2008 May; 29(5):573-9. PubMed ID: 18430365
[TBL] [Abstract][Full Text] [Related]
16. Nateglinide prevents fatty liver through up-regulation of lipid oxidation pathway in Goto-Kakizaki rats on a high-fat diet.
Mine T; Miura K; Kajioka T; Kitahara Y
Metabolism; 2008 Jan; 57(1):140-8. PubMed ID: 18078871
[TBL] [Abstract][Full Text] [Related]
17. Increased glucose production in mice overexpressing human fructose-1,6-bisphosphatase in the liver.
Visinoni S; Fam BC; Blair A; Rantzau C; Lamont BJ; Bouwman R; Watt MJ; Proietto J; Favaloro JM; Andrikopoulos S
Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1132-41. PubMed ID: 18780768
[TBL] [Abstract][Full Text] [Related]
18. Improvement in glucose tolerance as a result of enhanced insulin sensitivity during electroacupuncture in spontaneously diabetic Goto-Kakizaki rats.
Ishizaki N; Okushi N; Yano T; Yamamura Y
Metabolism; 2009 Oct; 58(10):1372-8. PubMed ID: 19501858
[TBL] [Abstract][Full Text] [Related]
19. Hypoglycemic effect of isoleucine involves increased muscle glucose uptake and whole body glucose oxidation and decreased hepatic gluconeogenesis.
Doi M; Yamaoka I; Nakayama M; Sugahara K; Yoshizawa F
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1683-93. PubMed ID: 17299083
[TBL] [Abstract][Full Text] [Related]
20. Fructose-1,6-bisphosphatase inhibitors. 1. Purine phosphonic acids as novel AMP mimics.
Dang Q; Brown BS; Liu Y; Rydzewski RM; Robinson ED; van Poelje PD; Reddy MR; Erion MD
J Med Chem; 2009 May; 52(9):2880-98. PubMed ID: 19348494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
